The woolly mammoth has been extinct for thousands of years, but Colossal Biosciences is pursuing technology that could help ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

EMERYVILLE, Calif. - Metagenomi, Inc. (NASDAQ: MGX), a biotechnology firm specializing in precision genetic medicines trading ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

New research from the Center for Physical Genomics and Engineering uncovers how 3D genome structures generate cellular memories, paving the way for advances in medicine and longevity through cellular ...

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...